Polymerase chain reaction

OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

Friday, June 5, 2020 - 12:00pm

"With the OPTI SARS-CoV-2 RT-PCR test kit, we benefit from an optimized workflow and a test that has proven to deliver the quality and accuracy that I would expect from a COVID-19 test.

Key Points: 
  • "With the OPTI SARS-CoV-2 RT-PCR test kit, we benefit from an optimized workflow and a test that has proven to deliver the quality and accuracy that I would expect from a COVID-19 test.
  • The OPTI SARS-CoV-2 RT-PCR test kituses real-time reverse transcription polymerase chain reaction (RT-PCR) technology and is designed to provide results in approximately 23.5 hours.
  • "The CE mark certification is an important step in advancing our efforts to support critical COVID-19 testing.
  • OPTI Medical Systems leverages advanced diagnostic technologies to develop reliable, cost-effective products that combine accuracy with convenience, ease of use and clinical flexibility.

Datametrex Reports Government Clearance To Fulfill Its First COVID-19 Test Kit Order

Wednesday, June 3, 2020 - 7:09pm

Each kit contains 288 individual tests, all of which can be completed in one hour.

Key Points: 
  • Each kit contains 288 individual tests, all of which can be completed in one hour.
  • The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order.
  • Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.
  • Security clearance backlogs continue to streamline as Governments align with the World Health Organizations remarks on the importance of testing.

Nucleic Acid Isolation and Purification Market Worth $4.8 Billion by 2025 - Exclusive Report by MarketsandMarkets™

Wednesday, June 3, 2020 - 3:30pm

On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.

Key Points: 
  • On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.
  • On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types.
  • Get 10% Customization on this Research Report:
    North America dominates the nucleic acid isolation and purification market during the forecast period.
  • In 2019, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe.

Nucleic Acid Isolation and Purification Market Worth $4.8 Billion by 2025 - Exclusive Report by MarketsandMarkets™

Wednesday, June 3, 2020 - 3:30pm

On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.

Key Points: 
  • On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.
  • On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types.
  • Get 10% Customization on this Research Report:
    North America dominates the nucleic acid isolation and purification market during the forecast period.
  • In 2019, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe.

Nephros to Present at the Virtual Summer Summit

Tuesday, June 2, 2020 - 12:30pm

Andy Astor, COO & CFO of Nephros, will be giving the presentation and answering questions from investors.

Key Points: 
  • Andy Astor, COO & CFO of Nephros, will be giving the presentation and answering questions from investors.
  • Nephros pathogen detection systems, including the PluraPath system, provide real-time data on waterborne bacteria and virus content to medical and water quality professionals.
  • Our products integrate Nephros ultrafilters with quantitative polymerase chain reaction (qPCR) technology to deliver actionable water pathogen information within an hour.
  • Nephros commercial filters, including AETHER brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment.

Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology

Saturday, May 30, 2020 - 3:30pm

Earlier this month, Tempus launched a diagnostic polymerase chain reaction (PCR) test for COVID-19.

Key Points: 
  • Earlier this month, Tempus launched a diagnostic polymerase chain reaction (PCR) test for COVID-19.
  • Tempus on-demand virtual case review system provides clinical support to physicians and care teams in a timely manner when an in-person meeting isnt possible.
  • Tempus has launched a large research collaboration to structure data for up to 50,000 COVID-19 positive patients.
  • As part of the IRB approved study, Tempus is partnering with providers to collect data on COVID-19 patients, which Tempus is structuring and de-identifying without cost.

Dante Labs Launches Most-Affordable, Pan-European Coronavirus Tests for Current Infection (PCR Swab) and Antibodies

Friday, May 29, 2020 - 6:48pm

Dante Labs announced its new pan-European, COVID-19 tests for both antibodies and current infection with at-home collection kits and premium medical shipping - to help 300 million Europeans get back to normal life.

Key Points: 
  • Dante Labs announced its new pan-European, COVID-19 tests for both antibodies and current infection with at-home collection kits and premium medical shipping - to help 300 million Europeans get back to normal life.
  • LONDON, May 29, 2020 /PRNewswire/ -- Dante Labs announced today two new premium COVID-19 testing solutions, to identify antibodies and current infection (PCR swab) at affordable prices, to help people get back to normal life.
  • Dante Labs released premium tests, based on validated, certified technologies, with premium shipping and add-on services, at affordable prices.
  • Dante Labs leveraged its existing technology developed for whole genome sequencing and interpretation to quickly scale up a high-capacity, highly automated testing solution for both current infection and antibodies for COVID-19.

Swift Biosciences Enables COVID-19 Surveillance with NGS of Low Titer SARS-CoV-2 Specimens

Thursday, May 28, 2020 - 2:00pm

Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift's assay enables research and surveillance activities by accommodating the low viral copy titers found in clinical specimens.

Key Points: 
  • Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift's assay enables research and surveillance activities by accommodating the low viral copy titers found in clinical specimens.
  • The two-round PCR kit supports high throughput processing by converting and enriching viral cDNA into multiplexed, NGS-ready libraries.
  • Following presence/absence assessment using qRT-PCR, excess cDNA was used as input into the Swift SNAP workflow to establish an NGS-based mutation profile for public health surveillance.
  • Swift Biosciences develops and commercializes NGS Library Preparation Kits that enable technologies for genomics, translational, and clinical research.

LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory

Thursday, May 28, 2020 - 12:55pm

Given the highly contagious nature of this virus, this is a long time to wait.

Key Points: 
  • Given the highly contagious nature of this virus, this is a long time to wait.
  • Until these studies are completed and the FDA grants LexaGenes instrument EUA for COVID-19 testing, all work using LexaGene instruments is classified as Research Use Only and cannot be used for human clinical diagnostics.
  • End-users simply need to collect a sample, load it onto the instrument with a sample preparation cartridge, enter sample ID and press go.
  • The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Global Molecular Diagnostics Market Analysis, Trends and Forecasts with Profiles of Leading Players Including Abbott Laboratories, bioMrieux SA, Cepheid, Hologic Inc. and Thermo Fischer Scientific Inc.

Wednesday, May 27, 2020 - 3:30pm

DUBLIN, May 27, 2020 /PRNewswire/ -- The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 27, 2020 /PRNewswire/ -- The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry.
  • The PCR market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned.
  • In Japan, the PCR segment will reach a market size of US$200.2 Million by the close of the analysis period.